The Diagnostic Imaging ultrasound modality focus page provides information, videos, podcasts, and the latest news about industry product developments, trial results, screening guidelines, and protocol guidance that touch on the use of ultrasound across the healthcare continuum, from cardiovascular, breast, abdominal, neurological imaging, and more, including point-of-care ultrasound.
June 6th 2023
In order to facilitate optimal detection and assessment of liver fibrosis and steatosis, the newly launched Hepatus 6 Diagnostic Ultrasound System offers the capabilities of real-time two-dimensional ultrasound with visual transient elastography in one device.
Could Controlled Imaging Rein in Suboptimal Use of MRI, CT and Ultrasound Exams?April 24th 2023
Lamenting a lack of control over imaging requests from referring clinicians, this author suggests that a more collaborative approach between referrers and radiologists may facilitate more efficient use of imaging.
BD Launches Ultrasound Guidance Modality to Facilitate Optimal IV AccessApril 11th 2023
The BD Prevue™ II Peripheral Vascular Access System reportedly offers real-time needle depth markers that may reduce multiple needlestick attempts and allow easier placement of intravenous (IV) access in high-risk patients.
Study Finds AI More Effective Than Sonographer Interpretation of Cardiac Function on EchocardiogramsApril 5th 2023
Based on a review of 3,495 echocardiographic studies to evaluate left ventricular ejection fraction (LVEF), researchers found that cardiologists changed initial artificial intelligence (AI) assessment 16.8 percent of the time and initial sonographer assessment 27.2 percent of the time.
AI-Enabled Lung Assessment Tool for Handheld Ultrasound Gets FDA NodApril 4th 2023
The artificial intelligence (AI) powered Auto B-line Counter, which reportedly produces a B-line count from a six-second ultrasound clip, may facilitate more expedient and consistent assessment of abnormal lung function.
Automated Breast Ultrasound: Is it a Viable Second-Look Option for Women with Dense Breasts?April 4th 2023
Emerging research shows the adjunctive use of automated breast ultrasound with mammography has similar sensitivity for breast cancer detection as adjunctive handheld ultrasound but may offer reduced false-positive rates in women with dense breasts.
Ultrasound-Based Tool May Help Differentiate Renal Fibrosis in Patients with Chronic Kidney DiseaseMarch 30th 2023
Smart-CKD, an ultrasound-derived, computer-aided diagnosis (CAD) tool, demonstrated an area under the curve of 81 percent and an 83 percent sensitivity rate in a validation cohort for differentiating between mild and moderate to severe fibrosis in patients with chronic kidney disease.
Can Ultrasound Renal Denervation be a Game-Changer for Reducing Blood Pressure?March 1st 2023
Findings from three randomized trials of ultrasound renal denervation revealed a significant reduction in daytime ambulatory systolic blood pressure in patients with varying levels of hypertension.
Clarius Mobile Health Gets FDA Nod for AI Ultrasound Musculoskeletal Imaging ModelFebruary 1st 2023
In what is reportedly the first Food and Drug Administration (FDA) 510(k) clearance for the use of artificial intelligence (AI) for musculoskeletal ultrasound, the model provides automated measurements of tendons in the knee, ankle, and foot.
Can Multimodal AI Improve Cancer Detection in Dense Breasts?January 20th 2023
Emerging research suggests combined artificial intelligence (AI) assessment of digital mammography and automated 3D breast ultrasound provides enhanced detection of breast cancer in women with dense breasts and may be a viable alternative in areas where radiologists are scarce.
Pie Medical Imaging Launches AI-Powered Echocardiography PlatformJanuary 13th 2023
CAAS Qardia 2.0, an updated version of the CAAS Qardia echocardiography software platform, reportedly incorporates artificial intelligence (AI)-enabled workflows, and provides enhanced imaging and analysis of key cardiac measures.
Can Deep Learning Enhance Ultrasound Assessment of Hepatic Steatosis in Patients with NAFLD?January 5th 2023
In a new prospective study, an emerging deep learning model, which incorporates parametric mapping with quantitative ultrasound to estimate liver fat fraction, demonstrated a 90 percent sensitivity rate and a 91 percent specificity rate for diagnosing hepatic steatosis in patients with non-alcoholic fatty liver disease (NAFLD).